CDC formally stops recommending hepatitis B vaccines for all newborns

Wednesday, December 17, 2025 -The Centers for Disease Control and Prevention (CDC) has officially updated its guidance, no longer recommending routine hepatitis B vaccination for all newborns. 

The shift reflects evolving scientific evidence and targeted risk assessments, prioritizing vaccination for infants at higher risk of exposure rather than a blanket approach. Healthcare providers are now adjusting protocols to align with the revised guidance.

Medical experts stress that while universal newborn vaccination is being scaled back, high-risk infants—such as those born to hepatitis B-positive mothers—will still receive timely protection. 

The decision also underscores the importance of individualized care and informed discussions between parents and pediatricians about vaccination schedules. Hospitals and clinics are implementing updated screening and documentation processes to ensure the transition is smooth and safe.

For parents and the healthcare system, the CDC’s new stance highlights a move toward precision public health, balancing safety with efficiency. It reinforces the need for awareness, proactive consultation with medical professionals, and adherence to targeted preventive measures. 

By focusing resources where they are most needed, the shift aims to optimize outcomes while maintaining public trust in vaccination programs.